HAPPYMINI® IN THE HALLUX RIGIDUS

 

The ISIAT 2019 held in Lisbon in October was the occasion for LABRHA to present a study about HAppyMini® in the Hallux Rigidus (Osteoarthritis of the first metatarso-phalangeal joint).

This prospective open-label multicentre pilot trial was conducted on 65 patients and safety was very good : no severe or systemic adverse events were observed.

 

SEE THE COMPLETE PRESENTATION